AGILE THERAPEUTICS INC Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2015 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Agile Therapeutics Inc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2015 to Q2 2024.
  • Agile Therapeutics Inc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $284K, a 41.1% decline year-over-year.
  • Agile Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2014 was $1.38M, a 3.2% increase from 2013.
  • Agile Therapeutics Inc annual Share-based Payment Arrangement, Expense for 2013 was $1.34M, a 101% increase from 2012.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $284K -$198K -41.1% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $333K -$165K -33.1% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q2 2023 $482K -$187K -28% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-12
Q1 2023 $498K -$266K -34.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q3 2022 $536K -$351K -39.6% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-07
Q2 2022 $669K -$174K -20.6% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $764K +$22K +2.97% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q3 2021 $887K +$240K +37.1% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 $843K +$4K +0.48% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $742K +$121K +19.5% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q3 2020 $647K +$269K +71.2% Jul 1, 2020 Sep 30, 2020 10-Q/A 2021-12-30
Q2 2020 $839K +$360K +75.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-07-26
Q1 2020 $621K +$131K +26.7% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-04
Q3 2019 $378K -$343K -47.6% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $479K -$508K -51.5% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-11
Q1 2019 $490K -$629K -56.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-05
Q3 2018 $721K -$246K -25.4% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-28
Q2 2018 $987K +$62K +6.7% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-01
Q1 2018 $1.12M +$284K +34% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-03
Q3 2017 $967K +$27K +2.87% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-02
Q2 2017 $925K -$30K -3.14% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 $835K +$124K +17.4% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-07
Q3 2016 $940K +$194K +26% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-06
Q2 2016 $955K +$217K +29.4% Apr 1, 2016 Jun 30, 2016 10-Q 2017-07-28
Q1 2016 $711K Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q3 2015 $746K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 $738K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.